Advertisement

Topics

Latest "Damon Runyon Cancer Research Foundation" News Stories

19:28 EDT 19th July 2018 | BioPortfolio

Here are the most relevant search results for "Damon Runyon Cancer Research Foundation" found in our extensive news archives from over 250 global news sources.

More Information about Damon Runyon Cancer Research Foundation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Damon Runyon Cancer Research Foundation for you to read. Along with our medical data and news we also list Damon Runyon Cancer Research Foundation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Damon Runyon Cancer Research Foundation Companies for you to search.

Showing "Damon Runyon Cancer Research Foundation" News Articles 1–25 of 39,000+

Thursday 19th July 2018

Diabetes increases the risk of cancer, with a higher risk in women

Diabetes is a risk factor for all-site cancer for both men and women, but the increased risk is higher in women than in men, according to a new article in Diabetologia (the journal of the European Association for the Study of Diabetes). Cancer is the...


20182023 Global HPV Testing Consumption Market Report [Report Updated: 06062018] Prices from USD $4660

In this report, LP Information covers the present scenario with the base year being 2017 and the growth prospects of global HPV Testing market for 20182023.The human papillomavirus HPV test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three subsegments,...

Thailand Pet Food Market Analysis of Growth, Trends, and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $3250

The Thailand Pet Food Market is expected to register a significant CAGR during the forecast period, 2018 to 2023. With rapid urbanization, the growth of ecommerce, increase in awareness of animal welfare, increase in petproduct information availability and the increase in the locals pushing back plans for marriage and/or children, the pet ownership is growing steadily thereby fuelling the pet food...


Novel Combinations Advance Through RCC Pipeline

Peter J. Van Veldhuizen, MD, discusses available and emerging therapies for patients with kidney cancer.

Photo-Me International () - Laundry opportunities and Japanese restructuring

Edison Investment Research - Consumer staples - Photo-Me International: Photo-Me’s (PHTM’s) FY18 results confirmed a successful business model divided by mutually exclusive sectors. A choppy market in Asia squeezed segment revenues but restructuring plans potentially improve profitability beyond FY19. FX headwinds and reduced tax benefited margins, although politically driven tax break...

Pan African Resources (PAF) - EGM's Parthian shot

Edison Investment Research - Mining - Pan African Resources: On 12 July 2018, Pan African Resources (PAF) announced that production to the end of June was 160,421oz cf prior guidance of 157-160koz for the year, with the outperformance exclusively attributable to underground operations at Evander (EGM). More significantly, for the first time management provided guidance of 170koz for FY19, which wa...

Euromoney Institutional Investor (ERM) - On track

Edison Investment Research - Media - Euromoney Institutional Investor: Euromoney's Q3 trading update shows little change from the position at the interims in May, with overall underlying revenues flat. This, however, masks divergent segmental performances. Structural issues in the asset management sector persist, while the pricing, data and market-intelligence subscription revenues are relatively ...

Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia

BEIJING, July 19, 2018 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, today announced the grand opening of Anderson Biotech Company Limited and Royal OncoCare Hospitality as two wholly owned subsidiaries of Yisheng Biop...

Global Superfood-based Packaged Snacks Market to Post a CAGR of 13% by 2022 | Technavio

The global superfood-based packaged snacks market is expected to post a CAGR of close to 13% during the period 2018-2022, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180719005920/en/ Technavio has

Global Packaged Turmeric-based Beverages Market to Post a CAGR of 21%| Technavio

The packaged turmeric-based beverages market is expected to post a CAGR of nearly 21% during the period 2018-2022, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180719005854/en/ Technavio has publ

Vivli Launches Clinical Research Data-Sharing Platform

David RathsOn July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

BIO Announces Dr. Larry Walker as the Legacy and Leadership Award Recipient at the 2018 BIO World Congress

The Biotechnology Innovation Organization (BIO) today presented Dr. Larry Walker, co-editor in chief for the journal “Industrial Biotechnology,” with the third annual BIO Leadership and Legacy Award in Industrial Biotechnology and Agriculture. The award presentation took place during a lunch plenary session at the 2018 BIO World Congress on Industrial ...

Broward Health Medical Center Designated an Aetna (Institute of Quality® / Institute of Excellence™)

Broward Health Medical Center has been designated an Aetna Institute of Quality® (IOQ) Cardiac Care Facility for the Cardiac Medical Intervention, Rhythm and Surgery programs for comprehensive heart and vascular treatment. Aetna makes information about the quality and cost of health care services available to its members to help them make informe...

Low/no calorie soft drinks linked to improved outcomes in advanced colon cancer patients

Drinking artificially-sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and cancer death, a team of investigators led by a Yale Cancer Center scientist has found. The study was published today in the journal...

Merck Reinforces Commitment to Responsible Pricing

Merck (NYSE:MRK), known as MSD outside the United States and Canada, has a long history of responsible pricing. In 2017, Merck issued its second annual Pricing Action Transparency Report, which showed that net prices across Merck’s U.S. product portfolio declined by 1.9 percent. We believe that further changes are still necessary to help reduce patient o...

Atezolizumab Regimen Extends PFS in Frontline Nonsquamous NSCLC

Adding atezolizumab to pemetrexed and cisplatin or carboplatin in the frontline setting reduced the risk of disease progression or death versus chemotherapy alone in patients with advanced nonsquamous non–small cell lung cancer, according to findings from the phase III IMpower132 study.  

Monthly, High-Dose Vitamin D Supplements Found Not to Prevent Cancers

Vitamin D supplements don't seem protective against cancer, a JAMA Oncology study reports. Previous studies have found an inverse relationship between serum vitamin D levels...

Your NEJM Group Today: Patient Innovation / DOACs for VTE in Patients with Cancer / Wisc. Endocrinology Opportunity

Have a look at what we picked for you today: NEJM Catalyst: How much are clinicians opening up to patient innovation? NEJM Journal Watch...

The V Foundation Announces $2.5 Million in Research Grants to be Awarded through the Robin Roberts Cancer Survivorship Fund

Funds Made Possible by Charitable Donation from Bristol-Myers Squibb for Cancer Survivorship Research CARY, N.C. (PRWEB) July 19, 2018 The V Foundation for Cancer Research, a top-rated cancer research charity, is excited to announce that Bristol-Myers Squibb Company has provided a $2.5 million donation to the V Foundation for cancer survivorship research. The grant will be used by the V Foundatio...

"Peter Huber Prize" awarded to Joseph Michel and Florian Theobald

On June 13, 2018, the "Peter Huber Prize" of the Valerius Füner Foundation was awarded at the Achema. As the best graduates from the years 2016 and 2017, the winners this year are Joseph Michel and Florian Theobald. Michel received the award for his Master's thesis on the optimization and simulation of combined heat and power plants. Theobald was honored for his work developing new models....

FDA Puts Mersana Cancer Study on Partial Hold After Patient Death

A patient has died in a clinical trial testing Mersana Therapeutics’ lead cancer drug, and the FDA has put a partial hold on the early-stage study as a result. The partial hold means that no new patients will be enrolled in the Phase 1 clinical trial. But patients who are already participating in the study […]

Cancer Genetics Closes $2.625 million Convertible Note Financing

Cancer Genetics (NASDAQ:CGIX) has announced the closing of a $2.625 million convertible note financing with a single institutional investor. As quoted in the press release: John A. Roberts, Chief Executive Officer of Cancer Genetics, commented, “This capital raise helps the Company continue to execute on our strategy of consolidating operations and expanding our biopharma business. … Conti...

Diabetes Coaching Program Mastering Diabetes Joins American College of Lifestyle Medicine Corporate Roundtable

The American College of Lifestyle Medicine today announced that the diabetes coaching program Mastering Diabetes has joined its Lifestyle Medicine Corporate Roundtable. The Mastering Diabetes Program, founded by two people living with type 1 diabetes, reverses insulin resistance and transforms the lives of those living with all forms of diabetes using the power of low-fat, plant-based whole food n...

The ICMC: a new path for microbiome research

Prof Julian Marchesi of Imperial College London and Cardiff university outlines the beginnings and future goals of the ICMC. He describes their current work which is looking at how the microbial composition of the gut can predict firstly tumour presence,...

The microbiome and cancer: cause or correlation?

James Kinross from Imperial College London discusses current status of the microbiome with context to cancer. He describes the increasing number of associations between the microbiome and cancer, and how there is increasing literature suggesting...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks